Suppression of hepatitis C virus replicon by TGF-beta. (Q40475340)

20 September 2017

Suppression of hepatitis C virus replicon by TGF-beta. (English)

1 reference

20 September 2017

1 reference

Takayuki Murata

1

1 reference

20 September 2017

Takayuki Ohshima

2

1 reference

20 September 2017

Masashi Yamaji

3

1 reference

20 September 2017

Masahiro Hosaka

4

1 reference

20 September 2017

Yusuke Miyanari

5

1 reference

20 September 2017

Makoto Hijikata

6

1 reference

20 September 2017

Kunitada Shimotohno

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

20 September 2017

1 reference

20 September 2017

331

1 reference

20 September 2017

407-417

1 reference

20 September 2017

2

1 reference

Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Efficient initiation of HCV RNA replication in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Parenchymal transforming growth factor beta-1: Its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Histopathology of hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Mechanism of the interferon alpha response against hepatitis C virus replicons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Smad6 inhibits signalling by the TGF-beta superfamily.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Subgenomic replicon derived from a cell line infected with the hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Smads bind directly to the Jun family of AP-1 transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

TGF-beta signaling by Smad proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Transforming growth factor-beta 1 in chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Transforming Growth Factor-β-mediated Signaling via the p38 MAP Kinase Pathway Activates Smad-dependent Transcription through SUMO-1 Modification of Smad4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Regulation of cell proliferation by Smad proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Reduced plasma transforming growth factor-beta1 levels in patients with chronic hepatitis C after interferon-alpha therapy: association with regression of hepatic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

Interleukin-1 Inhibits Hepatitis C Virus Subgenomic RNA Replication by Activation of Extracellular Regulated Kinase Pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.036

10.1016/J.VIROL.2004.10.036

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference